|
1-10 (of 54) related articles
Items per page
| |
|
1. Studies in Galveston.
SCH 417690 (vicraviroc) is a new HIV medication that is under investigation and not yet approved by the Food and Drug Administration (FDA). It is ... (PERIODICAL ARTICLE)
2. SMART Study.
The SMART Study continues enrollment in Houston and around the world. SMART stands for Strategies for the Management of Anti-Retroviral Therapy. The study will involve ... (PERIODICAL ARTICLE)
3. Baylor College of Medicine.
Cytomegalovirus (CMV) is a very common virus that infects many HIV-negative and HIV+ people in the US. CMV can infect many different parts of the ... (PERIODICAL ARTICLE)
4. The immune system (Part 1 of 2): T cells, B cells, and
cytokines.
The immune system is a complex system whose main job is to protect the body from foreign invaders like bacteria or viruses. The immune system ... (PERIODICAL ARTICLE)
5. Useful resources.
* Want more coverage of the Retrovirus Conference? Find abstracts, posters, and even recorded presentations at www.retroconference.org * Search HIV/AIDS clinical trials by topic, state, ... (PERIODICAL ARTICLE)
6. Is an undetectable viral load
necessary?
Achieving an undetectable viral load is not always possible. Instead, some patients stay at a detectable, but moderate, level for years. This is sometimes called ... (PERIODICAL ARTICLE)
7. STD dangers.
Syphilis, a sexually transmitted disease (STD), is caused by a type of bacteria and is spread through direct contact with a syphilis sore (also called ... (PERIODICAL ARTICLE)
8. First hepatitis C treatment approved for co-infected
patients.
In February 2005, the FDA approved the combination of Pegasys (peg-Interferon) and Copegus (ribavirin) for the treatment of hepatitis C virus (HCV) in HIV+ patients. (PERIODICAL ARTICLE)
9. Liver toxicity warning.
Patients taking either boosted or unboosted Invirase (saquinavir, hard gel capsules) or Fortavase (saquinavir, soft-gel capsules) should not take rifampin (brand names include Rifadin and ... (PERIODICAL ARTICLE)
10. Pregnant women should not use
Crixivan.
The protease inhibitor Crixivan should not be used in HIV+ pregnant women. New data have shown that blood levels of Crixivan are lower in pregnant ... (PERIODICAL ARTICLE) | |
|
1-10 (of 54) related articles
Items per page
|